AUTOIMMUNE ENCEPHALITIS
Clinical trials for AUTOIMMUNE ENCEPHALITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE ENCEPHALITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug aims to block brain attacks in autoimmune encephalitis
Disease control CompletedThis early-stage trial tested a new drug called ART5803 in 64 healthy adults to see if it is safe. ART5803 is a lab-made antibody designed to block harmful immune proteins that attack the brain in autoimmune encephalitis. The study gave single or multiple doses and compared them …
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can we predict who will relapse after brain inflammation?
Knowledge-focused CompletedThis study examines a rare brain disease called anti-LGI1 encephalitis, where the immune system attacks a protein in the brain, causing memory loss, confusion, and seizures. Researchers will review medical records from 112 patients across five hospitals in Eastern China to see ho…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Sponsor: Shen Chun-Hong • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Healthy volunteers help test new drug for brain inflammation
Knowledge-focused CompletedThis early-stage study tested a single dose of a new drug called ART5803 in 7 healthy adults to see if it is safe and how it interacts with another medicine (IVIG). The goal was to gather information for future research on autoimmune encephalitis, a condition where the immune sys…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Life after a rare brain disease: what happens to patients in the long run?
Knowledge-focused CompletedThis study looked at 20 adults who had NMDA receptor encephalitis, a rare brain condition that can cause psychosis, memory loss, and seizures. Researchers used questionnaires to measure thinking skills, mood, fatigue, and quality of life after the acute phase. The goal was to und…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC